Follow the people · Insider
Jayson Rieger
Jayson Rieger files insider transactions with the SEC as a ceo and president of Verrica Pharmaceuticals (VRCA). We hold 2 disclosed purchases and sales filed since 6 November 2024, 2 of them in the last 90 days.
- Files forVRCA
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure18 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 6 November 2024 — 17 August 2026CEO and President · Verrica Pharmaceuticals (VRCA)11 Form 4 lines · source: SEC Form 4
Everything they disclosed
11 entries, newest first — one per disclosure report, one per Form 4 line- ▲ bought on the open market 20,000 shares of Verrica PharmaceuticalsSEC Form 418 August 2026Common Stock · traded 14 August 2026 · filed 18 August 2026
- ▲ bought on the open market 5,000 shares of Verrica PharmaceuticalsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- was granted 512,269 shares of Verrica Pharmaceuticals (a derivative holding)SEC Form 49 June 2026Employee Stock Option (right to buy) · traded 5 June 2026 · filed 9 June 2026
- ▲ bought on the open market 23,577 shares of Verrica Pharmaceuticals (a derivative holding)SEC Form 425 November 2025Series C Warrant (right to buy) · traded 25 November 2025 · filed 25 November 2025
- ▲ bought on the open market 94,311 shares of Verrica PharmaceuticalsSEC Form 425 November 2025Common Stock · traded 25 November 2025 · filed 25 November 2025
- was granted 850,000 shares of Verrica Pharmaceuticals (a derivative holding)SEC Form 418 March 2025Employee Stock Option (right to buy) · traded 14 March 2025 · filed 18 March 2025
- ▲ bought on the open market 140,449 shares of Verrica Pharmaceuticals (a derivative holding)SEC Form 426 November 2024Series A Warrants (right to buy) · traded 22 November 2024 · filed 26 November 2024
- ▲ bought on the open market 140,449 shares of Verrica Pharmaceuticals (a derivative holding)SEC Form 426 November 2024Series B Warrants (right to buy) · traded 22 November 2024 · filed 26 November 2024
- ▲ bought on the open market 280,898 shares of Verrica PharmaceuticalsSEC Form 426 November 2024Common Stock · traded 22 November 2024 · filed 26 November 2024
- gave away 50,000 shares of Verrica PharmaceuticalsSEC Form 426 November 2024Common Stock · traded 26 November 2024 · filed 26 November 2024
- was granted 2,000,000 shares of Verrica Pharmaceuticals (a derivative holding)SEC Form 46 November 2024Employee Stock Option (right to buy) · traded 6 November 2024 · filed 6 November 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.